%D8%A8%D9%8A%D8%B1%D8%A7%D8%B2%D9%8A%D9%86%D8%A7%D9%85%D9%8A%D8%AF%D9%BE%DB%8C%D8%B1%D8%A7%D8%B2%DB%8C%D9%86%D8%A7%D9%85%DB%8C%D8%AF%D0%9F%D1%96%D1%80%D0%B0%D0%B7%D1%96%D0%BD%D0%B0%D0%BC%D1%96%D0%B4PirazinamidaCategory:PyrazinamidePyrasinamidPyrazinamidPyrazinamidPyrazinamidePirazinamida%D9%BE%DB%8C%D8%B1%D8%A7%D8%B2%DB%8C%D9%86%D8%A7%D9%85%DB%8C%D8%AFPyratsiiniamidiPyrazinamidePirazinamidPirazinamide%E3%83%94%E3%83%A9%E3%82%B8%E3%83%8A%E3%83%9F%E3%83%89%ED%94%BC%EB%9D%BC%EC%A7%84%EC%95%84%EB%A7%88%EC%9D%B4%EB%93%9CPyrazinamide%E0%AC%AA%E0%AC%BE%E0%AC%87%E0%AC%B0%E0%AC%BE%E0%AC%9C%E0%AC%BF%E0%AC%A8%E0%AC%BE%E0%AC%AE%E0%AC%BE%E0%AC%87%E0%AC%A1PirazynamidPirazinamid%C4%83%D0%9F%D0%B8%D1%80%D0%B0%D0%B7%D0%B8%D0%BD%D0%B0%D0%BC%D0%B8%D0%B4PirazinamidPirazinamidPirazinamid%D0%9F%D1%96%D1%80%D0%B0%D0%B7%D0%B8%D0%BD%D0%B0%D0%BC%D1%96%D0%B4PyrazinamideQ417571%E5%90%A1%E5%97%AA%E9%85%B0%E8%83%BA
about
P2176
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisClinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis AgentsPopulation Pharmacokinetics of Anti-tuberculosis Drugs in Children With TuberculosisNGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TBAnti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced HepatotoxicityControlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisEvaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)Pilot Clinical Trial of PRS TB Regimen I - Phase IIAdequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) TabletNovel Triple-dose Tuberculosis Retreatment RegimenClofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyEfficacy and Safety of Favipiravir in Management of COVID-19
P4844
The search for new sterilizing anti-tuberculosis drugs.Drug induced hepatitis with anti-tubercular chemotherapy: challenges and difficulties in treatment.Primary drug resistance against Mycobacterium tuberculosis in Karachi.Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, PakistanMODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of Pyrazinamide Resistance from Sputum SamplesA Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence SettingpncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspectsMutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin inPharmaceutical Cocrystal Formation of Pyrazinamide with 3-Hydroxybenzoic Acid: A Terahertz and Raman Vibrational Spectroscopies Study
P921
Q61865065-07AB4966-835B-4BC0-97C0-D363B74B536BQ61894565-FFC3ECAC-0DBD-4B79-AE5F-F39F839346ACQ61904384-E88C18F7-FC5C-468A-B5A0-A345EBE196B9Q61907366-B0E2BCAB-8DE9-444F-9855-5A3392D72A5CQ61966022-61357E05-3114-44ED-89B4-E6B2471CD3A8Q61981168-79558116-D786-4766-8566-B8D1F17B0874Q63318459-5235495F-052A-4663-AE3E-6872EF7DF57DQ63399295-11BA542E-6C65-45CC-A13B-29BE778CF4EFQ63591632-011176FD-A191-452A-A8C6-278B9B83E939Q87076591-A6B4CD21-B8A9-4DD5-B97A-17ED56057B2DQ87931585-BF72A80F-5AF6-483E-A6CD-FA425A99BFBEQ92392243-6CB773B6-B878-4481-8658-664D3DC22444
P4844
Q35672648-2EB32F2E-4208-48A5-88B2-BCB9F97DDB2AQ37208229-9F9AB6E9-D1BB-4A80-A841-4347C8763A3FQ46563703-A6593256-B955-4DCC-ADB7-7ABCCD307363Q61798483-67071CB7-147F-406E-8D53-9D2C13B7B522Q61806240-19A74601-B4E5-4B6C-80B7-521E885C133DQ61806719-FEE96611-1687-4092-A3FE-992421A4BD81Q64135866-B58F5858-B0E6-453E-B634-20E8AE1B3211Q64228505-E87E3D7C-F497-4214-96D7-A8EB9DB518DAQ64267888-6E5A7389-AEDC-468E-8A51-536EFC7C2BA4
P921
description
Antituberkulotikum
@cs
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Pirazinamid
@id
Pirazinamid
@sh
Pirazinamid
@sr
Pirazinamid
@tr
Pirazinamida
@es
Pirazinamide
@it
Pirazinamidă
@ro
Pyratsiiniamidi
@fi
Pyrazinamid
@cs
Pyrazinamid
@da
type
label
Pirazinamid
@id
Pirazinamid
@sh
Pirazinamid
@sr
Pirazinamid
@tr
Pirazinamida
@es
Pirazinamide
@it
Pirazinamidă
@ro
Pyratsiiniamidi
@fi
Pyrazinamid
@cs
Pyrazinamid
@da
altLabel
2-carbamylpyrazine
@en
2-karbamylpyrazin
@cs
2-pyrazinecarboxamide
@en
Aldinamide
@en
PZA
@cy
PZA
@en
Pirazinamida
@en
Pirazinamide
@en
Pyrazinamid
@en
Pyrazinamida
@en
prefLabel
Pirazinamid
@id
Pirazinamid
@sh
Pirazinamid
@sr
Pirazinamid
@tr
Pirazinamida
@es
Pirazinamide
@it
Pirazinamidă
@ro
Pyratsiiniamidi
@fi
Pyrazinamid
@cs
Pyrazinamid
@da